How Ketamine Rewires AMPA Receptors to Treat Depression: Molecular Observation in Humans

How Ketamine Rewires Receptors to Beat Depression TL;DR: Using PET imaging to directly visualize AMPA receptors in the living human brain, researchers discovered that ketamine’s rapid antidepressant effect works by reshuffling these receptors across specific brain regions in patients with treatment-resistant depression — and where they go predicts who will respond to the drug. Nearly …

Read more

How Blocking DUSP6 Extends Ketamine’s Antidepressant Effect to Months

How Scientists Turned a Brief Ketamine High into a Two-Month Antidepressant Effect TL;DR: Blocking DUSP6 protein alongside ketamine extends antidepressant effects from 2 weeks to 4+ weeks in mice, potentially offering single-dose treatment instead of repeated infusions. Ketamine works like almost nothing else in psychiatry. A single infusion can lift severe depression within hours, even …

Read more

Fluorinated Psilocin Derivative Cuts Psychedelic Effects 75% While Preserving Antidepressant Activity

Fluorinated Psilocin: The Sub-Hallucinogenic Breakthrough TL;DR: Chemists designed a new psilocin derivative with fluorine modifications that induces sub-hallucinogenic effects in mice, sidestepping the acute psychological effects of classic psychedelics while retaining therapeutic serotonin receptor activity. Psilocybin has emerged as a clinical darling—mounting evidence shows rapid relief for depression, anxiety, and cluster headaches. But there’s a …

Read more

Psychedelics Double 5-Hz Brain Oscillations in Visual Cortex to Produce Hallucinations

How Psychedelics Hijack Brain Waves to Create Hallucinations TL;DR: A psychedelic drug that activates serotonin receptors dramatically amplifies slow 5-Hz brain oscillations in visual and memory regions, suggesting a mechanism for how hallucinogens distort perception by letting internal signals override external reality. Visual perception feels stable, seamless, continuous. But that stability is an illusion orchestrated …

Read more

Type 2 Diabetes vs. Depression and Anxiety: The Bidirectional Relationship

Diabetes and Depression Are Not Just Comorbidities—They Drive Each Other TL;DR: Diabetes and depression form a vicious cycle: high blood sugar triggers neuroinflammation and HPA axis dysfunction that cause depression, while depression sabotages blood sugar control through behavioral and metabolic pathways. Doctors have known for years that depression and type 2 diabetes often occur together. …

Read more

Naltrexone Weakens Ketamine’s Antidepressant Effects, Revealing an Opioid-Dependent Mechanism

Opioid System Activation is Required for Ketamine’s Antidepressant Effects Ketamine is fast—a single subanesthetic infusion reduces severe depression symptoms within hours, not weeks. But the mechanism remains incompletely understood. For nearly two decades, research assumed glutamate flooding the brain explained everything: ketamine blocks NMDA receptors on inhibitory neurons, releasing the brakes on glutamate release, which …

Read more

OPRM1 Gene Polymorphisms of A118G SNP Predict Opioid Effects

This study found that individuals with the AG/GG genotype of the A118G SNP in the OPRM1 gene experienced more pleasant and fewer unpleasant effects from hydromorphone compared to those with the AA genotype, suggesting genotype-based differences in opioid sensitivity. Highlights: Positive Effects: Participants with the AG/GG genotype reported significantly more positive effects (e.g., good effects, …

Read more

Cannabis (Marijuana) Addiction Linked to Altered Brain Connectivity (2024 Study)

Individuals at risk for cannabis use disorder (CUD) exhibit increased dynamic fluidity and altered connectivity patterns in brain networks, suggesting early changes in brain function that may contribute to cannabis addiction risk. Highlights: At-risk individuals for cannabis addiction show a greater number of meta-states and more frequent transitions between them, indicating higher dynamic fluidity in …

Read more

Probiotics Alter Clock Gene Expression in Depression to Improve Mood (2024 Study)

Probiotic treatment may influence core clock gene expression and metabolites in individuals with major depressive disorder (MDD), potentially linking gut microbiota to circadian rhythms and mood regulation. Highlights: CLOCK Gene Expression: The expression level of the CLOCK gene significantly increased only in individuals receiving probiotic treatment, suggesting a direct impact of probiotics on circadian rhythms. …

Read more

Omega-3 Fatty Acids & Souvenaid® May Slow Cognitive Decline in Alzheimer’s Disease (2024 Review)

Omega-3 supplements and Souvenaid® show potential in slowing cognitive decline in Alzheimer’s patients, though the evidence remains inconclusive. Highlights: Cognitive Decline Reduction: The CDR scale showed a significant reduction in cognitive decline progression with Omega-3 supplementation (SMD = −0.4127, 95% CI: [−0.5926; −0.2327]). Mixed Cognitive Outcomes: 58% of studies reported positive cognitive effects from Omega-3 …

Read more